Exclusive

Publication

Byline

Location

Delhi HC orders halt to 'Olymviq' promotion as Novo accuses Dr Reddy's of breach

New Delhi, April 28 -- The Delhi High Court on Tuesday ordered Dr. Reddy's Laboratories to give an undertaking that it will not communicate or promote its generic semaglutide drug under the brand name... Read More


Dr. Reddy's can supply leftover Olymviq stock to government hospitals after 30-day window

New Delhi, March 30 -- The Delhi High Court has allowed Dr. Reddy's Laboratories to supply any remaining stock of its semaglutide drug Olymviq to government hospitals after the expiry of a 30-day stoc... Read More


Delhi HC refuses to direct Dr Reddy's to junk 'Olymviq' stock

New Delhi, March 27 -- New Delhi, Mumbai : The Delhi High Court on Friday refused to allow the destruction of Dr Reddy's Laboratories Ltd's inventory of its generic semaglutide drug, Olymviq, while ... Read More